COP regimen: Difference between revisions

	WikiDoc Resources for COP regimen
Articles
Most recent articles on COP regimen Most cited articles on COP regimen Review articles on COP regimen Articles on COP regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on COP regimen Images of COP regimen Photos of COP regimen Podcasts & MP3s on COP regimen Videos on COP regimen
Evidence Based Medicine
Cochrane Collaboration on COP regimen Bandolier on COP regimen TRIP on COP regimen
Clinical Trials
Ongoing Trials on COP regimen at Clinical Trials.gov Trial results on COP regimen Clinical Trials on COP regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on COP regimen NICE Guidance on COP regimen NHS PRODIGY Guidance FDA on COP regimen CDC on COP regimen
Books
Books on COP regimen
News
COP regimen in the news Be alerted to news on COP regimen News trends on COP regimen
Commentary
Blogs on COP regimen
Definitions
Definitions of COP regimen
Patient Resources / Community
Patient resources on COP regimen Discussion groups on COP regimen Patient Handouts on COP regimen Directions to Hospitals Treating COP regimen Risk calculators and risk factors for COP regimen
Healthcare Provider Resources
Symptoms of COP regimen Causes & Risk Factors for COP regimen Diagnostic studies for COP regimen Treatment of COP regimen
Continuing Medical Education (CME)
CME Programs on COP regimen
International
COP regimen en Espanol COP regimen en Francais
Business
COP regimen in the Marketplace Patents on COP regimen
Experimental / Informatics
List of terms related to COP regimen

VisualWikitext

Latest revision as of 13:11, 12 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: CVP; CVP regimen; Cyclophosphamide/Vincristine/Prednisone

Overview

COP regimen refers to a regimen consisting of cyclophosphamide, vincristine, and prednisone used to treat Non Hodgkin's lymphoma.

Regimen

CCyclophosphamide

OVincristine (Oncovin)

PPrednisone

Indications

Non Hodgkin's lymphoma^[1]

References

↑ Luce JK, Gamble JF, Wilson HE, Monto RW, Isaacs BL, Palmer RL; et al. (1971). "Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma". Cancer. 28 (2): 306–17. PMID 4935774.

[pmid4935774-1] Luce JK, Gamble JF, Wilson HE, Monto RW, Isaacs BL, Palmer RL; et al. (1971). "Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma". Cancer. 28 (2): 306–17. PMID 4935774.

[1]

@@ Line 3: / Line 3: @@
 {{CMG}}; {{AE}} {{AV}}
-{{SK}}
+{{SK}} CVP; CVP regimen; Cyclophosphamide/Vincristine/Prednisone
 ==Overview==
-{{PAGENAME}} refers to a regimen consisting of xxx used to treat xxx.
+{{PAGENAME}} refers to a regimen consisting of [[cyclophosphamide]], [[vincristine]], and [[prednisone]] used to treat [[Non Hodgkin's lymphoma]].
 ==Regimen==
-{{chemo|x|xx}}
+{{chemo|C|Cyclophosphamide}}
-{{chemo|x|xx}}
+{{chemo|O|Vincristine (Oncovin)}}
-{{chemo|x|xx}}
+{{chemo|P|Prednisone}}
-{{chemo|x|xx}}
 ==Indications==
+* [[Non Hodgkin's lymphoma]]<ref name="pmid4935774">{{cite journal| author=Luce JK, Gamble JF, Wilson HE, Monto RW, Isaacs BL, Palmer RL et al.| title=Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma. | journal=Cancer | year= 1971 | volume= 28 | issue= 2 | pages= 306-17 | pmid=4935774 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4935774  }} </ref>
 ==References==